source
- Novocure's electric field therapy fails Phase 3 glioblastoma trial, not extending patient survivalNovocure announced on Thursday that its electric fields device, used together with standard chemoradiation, did not improve overall survival for patients with glioblastoma in a Phase 3 trial. The…
- Eli Lilly stops 340B discounts for dozens of hospitals that did not submit claims dataEli Lilly has begun removing the federally mandated 340B price discounts for a few dozen hospitals that have not provided the required claims data. The company said the step follows a warning it is…